共 97 条
[1]
Schulz KF(2005)Sample size calculations in randomised trials: mandatory and mystical Lancet 365 1348-53
[2]
Grimes DA(1989)Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 407-15
[3]
Jaeschke R(2011)A point of minimal important difference (MID): a critique of terminology and methods Expert Rev Pharmacoecon Outcomes Res 11 171-84
[4]
Singer J(2017)The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies J Clin Epidemiol 82 128-36
[5]
Guyatt GH(2018)DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial Trials 19 606-106.e2
[6]
King MT(2018)Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studies J Clin Epidemiol 101 87-98
[7]
Angst F(2017)Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Open 7 e015587-4
[8]
Aeschlimann A(2019) Rapid Recommendations BMJ Open 9 e028777-15
[9]
Angst J(2018)Minimal important differences for improvement in shoulder condition patient-reported outcomes: a systematic review to inform a JBJS Rev 6 e2-7
[10]
Cook JA(2017) Rapid Recommendation J Clin Epidemiol 89 188-8